ClinicalTrials.Veeva

Menu
N

National Institutes of Health | National Institutes of Health Clinical Center | Critical Care Medicine Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Androgen
Bosentan
Leniolisib
cyclophosphamide
ONC206
Ritonavir
STAR0602
sirolimus
doxorubicin
AZD6244

Parent organization

This site is a part of National Institutes of Health

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 48 total trials

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants with Advanced Solid Tumors (START-001)

This is an open label, multicenter, phase 1/2 study to assess the safety/tolerability and preliminary clinical activity of STAR0602 as a single agent...

Enrolling
Abdominal Neoplasm
Neoplasms by Site
Drug: STAR0602

This study is researching an experimental drug called mibavademab. The study is focused on participants with GLD who have been on metreleptin treatme...

Enrolling
Generalized Lipodystrophy
Drug: mibavademab

The purpose of this is study is to evaluate the long-term safety of DCCR (diazoxide choline) extended-release tablets) in patients with Prader-Willi...

Active, not recruiting
Prader-Willi Syndrome
Drug: DCCR

This is a 2-part, prospective, open-label, single arm, multicenter study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamic...

Active, not recruiting
APDS
Drug: Leniolisib

This is a 2-part, prospective, open-label, single arm, multicenter study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamic...

Active, not recruiting
APDS
Drug: Leniolisib

The primary objective of this Phase 1, open-label, dose-escalation, and exploratory study is to evaluate the safety and tolerability profile (establi...

Enrolling
Glioblastoma
Glial Tumor
Drug: ONC206

The study is a global, multi-center safety and efficacy trial of epcoritamab, an antibody also known as EPKINLY™ and GEN3013 (DuoBody®-CD3xCD20). Epc...

Enrolling
Small Lymphocytic Lymphoma
Treatment-naïve High Risk Chronic Lymphocytic Leukemia
Drug: Lenalidomide
Drug: rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone

This is a pediatric basket study to investigate the safety and efficacy of afamitresgene autoleucel in HLA-A\*02 eligible and MAGE-A4 positive subjec...

Enrolling
Osteosarcoma
Neuroblastoma
Genetic: Afamitresgene autoleucel

Trial sponsors

National Cancer Institute (NCI) logo
Actelion Pharmaceuticals logo
Boston Children's Hospital logo
Emory University logo
Mesoblast logo
National Institute of Allergy and Infectious Diseases (NIAID) logo
National Institutes of Health (NIH) logo
P
The University of Texas System (UT) logo
N

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems